Secure and Adaptive Implantable Biotherapeutic Agent Delivery Systems

The inventive concept relates to a family of implantable, nanoporous devices for delivering cellular and biotherapeutic agents in high-security, disaster relief, and extreme weather condition environments. These devices provide enhanced security, adaptability, and reliability in unique operational settings.

The original patent disclosed a metallic, nanoporous device for encapsulating cellular and biotherapeutic agents. However, the original design did not address the specific needs of high-security, disaster relief, and extreme weather condition environments. The new inventive concept addresses these limitations by introducing specialized variations and niche solutions tailored to these unique settings.

The inventive concept encompasses four primary embodiments: (1) a tamper-evident, metallic canister for high-security biotherapeutic agent delivery; (2) a nanoporous device for delivering cellular and biotherapeutic agents in disaster relief settings; (3) a rigid, through-porous membrane for extreme weather condition use; and (4) a selectively permeable, nanoporous canister for high-security facility use. Each embodiment is designed to promote repair of damaged or degenerated tissues in mammalian hosts while adapting to the specific challenges of its target environment.

The new inventive concept's novelty lies in its tailored solutions for high-security, disaster relief, and extreme weather condition environments. The inventive step resides in the integration of specialized features, such as tamper-evident seals, patterned surfaces, and selectively permeable membranes, to address the unique challenges of these environments.

Alternative embodiments of the inventive concept could include variations in membrane morphology, surface treatment patterns, and device geometries to further enhance adaptability and security in diverse operational settings.

The inventive concept has significant commercial potential in the biomedical and pharmaceutical industries, particularly in the areas of high-security biotherapeutic agent delivery, disaster relief, and extreme weather condition medical response. Target industries may include government agencies, pharmaceutical companies, and medical device manufacturers.